Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Pancreatic Cancer”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Early research (Phase 1)Active Not RecruitingNCT03889795
What this trial is testing

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Who this might be right for
Advanced Pancreatic CancerAdvanced Solid Tumor
Danae Hamouda, MD 15
Early research (Phase 1)Study completedNCT01918644
What this trial is testing

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more
University of Wisconsin, Madison 21
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Not applicableEnded earlyNCT04476537
What this trial is testing

RNA Precision Oncology in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Columbia University 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Early research (Phase 1)Ended earlyNCT01192763
What this trial is testing

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Early research (Phase 1)Study completedNCT01010945
What this trial is testing

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
OSI Pharmaceuticals 19
Early research (Phase 1)Study completedNCT01155453
What this trial is testing

Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced and Selected Solid Tumors
Novartis Pharmaceuticals 113
Testing effectiveness (Phase 2)Study completedNCT00609336
What this trial is testing

Perioperative Therapy for Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
University of Washington 35
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01234935
What this trial is testing

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+5 more
Translational Oncology Research International 8
Testing effectiveness (Phase 2)Looking for participantsNCT06844422
What this trial is testing

Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

Who this might be right for
Pancreatic Cancer
Shandong Cancer Hospital and Institute 37
Testing effectiveness (Phase 2)Ended earlyNCT00482625
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Intraductal Papillary Mucinous Neoplasm of the PancreasRecurrent Pancreatic CancerStage IA Pancreatic Cancer+4 more
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Ended earlyNCT02331251
What this trial is testing

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Who this might be right for
Advanced CancerBreast CancerSarcoma+3 more
Western Regional Medical Center 81
Early research (Phase 1)Ended earlyNCT05417386
What this trial is testing

FOLFIRINOX + NIS793 in Pancreatic Cancer

Who this might be right for
Pancreas CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Colin D. Weekes, M.D., PhD 4
Not applicableStudy completedNCT02432950
What this trial is testing

Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer

Who this might be right for
ObesityStage IA Breast CancerStage IB Breast Cancer+5 more
City of Hope Medical Center 21
Load More Results